Here's what to expect this week on Diagnostic Imaging.
In this week’s preview, here are some highlights of what you can expect to see coming soon:
In his monthly column, Editorial Board member Mina Makary, M.D., assistant professor of radiology at The Ohio State University Wexner Medical Center, takes on the topic of non-invasive virtual biopsy. Look for his blog later this week to see the case he lays out for why it’s a better, safer option for the future of cancer management.
For more of Makary’s blogs, click here.
When found early, thyroid cancer has a good prognosis, but it is typically diagnosed by needle biopsy. Recently published research reveals that combining photoacoustic and ultrasound images with artificial intelligence can lead to accurate diagnoses in a non-invasive way. Look for an article later this week that details the results of this study published in Cancer Research.
For more coverage of thyroid cancer and thyroid imaging, click here.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
The outlook for most men with prostate cancer is good, but proper treatment planning is essential. In a column this week, Yashbir Mehta, M.D., radiology oncologist from UroPartners, explores the role that CT plays in improving accuracy and augmenting patient comfort during the treatment planning process. Look for the article in the coming days.
For more coverage prostate cancer, click here.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.
Ultrasound-Guided Thermal Ablation Shows Low Recurrence of Thyroid Carcinoma at Five Years
June 16th 2025In a meta-analysis involving over 2,200 patients with T1NoMo papillary thyroid carcinoma, researchers noted 2 percent recurrence and no cases of lymph node metastasis five years after ultrasound-guided thermal ablation.